RxDoctor Payments Data

Jorge Go, MD

Gastroenterology · Cincinnati, OHNPI 1538366729

Payments from drug & device makers

$14,409in general payments, 2019–2025

Across 908 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Johnson & Johnson$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Gilead$716
  • Madrigal Pharmaceuticals$547
  • plus $5K from 36 others

What the payments were for

  • Food & beverage$14,19398%
  • Education$2162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,409 in reported general payments places this provider in the 75th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$138,642
Medicare patients
353
Services billed
2,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab23$637,383
Sandostatin Lar DepotOctreotide Acetate,mi-Spheres17$78,025
XifaxanRifaximin21$68,211
ZenpepLipase/Protease/Amylase11$42,141
CreonLipase/Protease/Amylase18$33,606
LinzessLinaclotide19$13,429
SutabSod Sulf/Pot Chloride/Mag Sulf27$4,395
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C26$3,535
Dexlansoprazole DrDexlansoprazole19$3,310
Esomeprazole Magnesium58$2,723
Omeprazole296$2,716
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates41$2,618
Pantoprazole Sodium179$1,625
Lubiprostone23$1,563
CholestyramineCholestyramine (With Sugar)14$1,267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$1,499$637,38323 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Plenvu$1,797$71,74647 claims
AbbVieCreon, Linzess$4,079$47,03537 claims
Aimmune Therapeutics, Inc.Zenpep$78$42,14111 claims
Braintree Laboratories, Inc.Sutab$14$4,39527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →